Application 077067
- Type
- ANDA
- Sponsor
- SUN PHARM INDS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NIMODIPINE | NIMODIPINE | CAPSULE;ORAL | 30MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077067-001 | NIMODIPINE | NIMODIPINE | 30MG | CAPSULE / ORAL | 2007-04-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077067-001 | NIMODIPINE | 30MG | CAPSULE / ORAL | 2007-04-17 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nimodipine | NIMODIPINE | BIONPHARMA INC. | e65d5108-22a2-4d87-a78d-15606f3cc9e2 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | Nimodipine NIMODIPINE |
| Nymalize | NIMODIPINE | Azurity Pharmaceuticals, Inc. | e660fa26-b5c4-4d6d-8887-9e22b6666a10 | 2024-08-30 | Warnings, Adverse reactions | NIMODIPINE |
| nimodipine | NIMODIPINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | a323ebd8-ef1b-439b-93d1-ba73a5b0127d | 2024-08-16 | Boxed warning, Warnings, Adverse reactions | nimodipine NIMODIPINE |
| Nimodipine | NIMODIPINE | Camber Pharmaceuticals, Inc. | f829de8b-fabd-4aec-ac8d-c9aaef7be55b | 2024-07-20 | Warnings, Adverse reactions | Nimodipine NIMODIPINE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57664-135 | Nimodipine | Nimodipine | Caraco Pharmaceutical Laboratories, Ltd. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9000 | ORIG | 2007-04-25 |